GlassScriptPhysician profile
Akshay Reddy
NPI 1720617376
$1,332.22
in general payments reported to CMS, 2019-2025
13 companies · $46.73 in 2025
The $46.73 reported for 2025 was less than what a typical Hospice and Palliative Medicine (Family Medicine) provider received nationally (typical 2025 total: $78.57).
See the full distribution for Hospice and Palliative Medicine (Family Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $403 · 2022: $828 · 2023: $32.97 · 2024: $22.07 · 2025: $46.73.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $102.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $101.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acadia Pharmaceuticals INC | $266.21 | 2022-2025 | Nuplazid |
| Abbvie INC. | $212.50 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $144.63 | 2021-2022 | |
| Horizon Therapeutics Plc | $130.31 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $124.99 | 2022 | |
| Viiv Healthcare Company | $119.43 | 2022 | |
| Kyowa Kirin, INC. | $115.53 | 2021 | |
| Biogen, INC. | $80.00 | 2022 | |
| Gilead Sciences, INC. | $55.25 | 2021 | |
| Neurocrine Biosciences, INC. | $28.33 | 2025 | |
| Opko Pharmaceuticals, LLC | $22.07 | 2024 | Rayaldee |
| Exact Sciences Corporation | $19.75 | 2023 | Cologuard Collection Kit |
| Merck Sharp & Dohme LLC | $13.22 | 2023 | Delstrigo, Pifeltro, Dificid |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Akshay Reddy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.